photo #1874045

ICYMI - Sep 9, 2019, just before the pandemic begins, BioNTech submitted their SEC filing acknowledging new mRNA drugs have substantial clinical risks, may not work, may cause harm, and are classified as gene therapy by the FDA, which creates increased regulatory burdens for them (unlike “vaccines”)https://www.sec.gov/Archives/edgar/data/1776985/000119312519241112/d635330df1.htm